SEARCH
= Registered usersThompson J. Mortality risk raised during induction with methadone in opioid substitution therapy. Practitioner Nov 2017;261(1809):8-11
Mortality risk raised during induction with methadone in opioid substitution therapy
23 Nov 2017
Patients undergoing opioid substitution treatment have an increased mortality risk during the induction phase with methadone but not with buprenorphine, a meta-analysis has found. Mortality risk is also raised in the period immediately after leaving treatment with both drugs.
This article can be accessed only if you are a paid-up subscriber to The Practitioner.